1. A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION. (21st February 2022) Authors: Crowley, E; Turner, D; Ma, C; Nguyen, T; McKay, H; Schneider, R; Silverberg, A; Muise, A; Feagan, B; Griffiths, A; Jairath, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗